W↗ / WALL STREET ZINE

If you invested $100 a month in Alnylam Pharmaceuticals

Buying $100 at each monthly close from November 2016 through October 2026, with dividends reinvested, turns $12,000.00 contributed into $15,956.36 as of October 29, 2026. Annualized money-weighted IRR: 5.65%.

Monthly scheduleInvestedValueAnnualized (money-weighted IRR)SPY same-schedule value (reinvested)
5 years · $50/month$3,000.00$2,447.89-8.23%$4,658.67 · 60 contributions · $3,000.00 invested · 2021-10 to 2026-10
5 years · $100/month$6,000.00$4,895.78-8.23%$9,317.33 · 60 contributions · $6,000.00 invested · 2021-10 to 2026-10
5 years · $500/month$30,000.00$24,478.90-8.23%$46,586.66 · 60 contributions · $30,000.00 invested · 2021-10 to 2026-10
10 years · $50/month$6,000.00$7,978.185.65%$13,474.72 · 120 contributions · $6,000.00 invested · 2016-10 to 2026-10
10 years · $100/month$12,000.00$15,956.365.65%$26,949.44 · 120 contributions · $12,000.00 invested · 2016-10 to 2026-10
10 years · $500/month$60,000.00$79,781.795.65%$134,747.18 · 120 contributions · $60,000.00 invested · 2016-10 to 2026-10
20 years · $50/month$12,000.00$56,777.5413.82%$56,585.20 · 240 contributions · $12,000.00 invested · 2006-10 to 2026-10
20 years · $100/month$24,000.00$113,555.0713.82%$113,170.40 · 240 contributions · $24,000.00 invested · 2006-10 to 2026-10
20 years · $500/month$120,000.00$567,775.3613.82%$565,852.00 · 240 contributions · $120,000.00 invested · 2006-10 to 2026-10

Asset last price date: 2026-10-29; SPY last price date: 2026-10-29. The latest month may be incomplete. Zero initial investment; contributions start the following month. Monthly observations are estimates, not executable trades. Fees, taxes and FX excluded. Curated surviving assets; delisted companies are absent. Not financial advice. Past performance doesn’t predict future returns.

REWIND THE MARKET

Monthly closing prices. No fees, taxes or FX.

YOUR INVESTMENT TODAY
$15,956.36

$3,956.36 total gain · 32.97% total return

Amount invested$12,000.00
Annualized (money-weighted IRR)5.65%
Investment multiple1.33×

● Your investment● S&P 500 (SPY)

Alnylam Pharmaceuticals history · Methodology

2006 · 2007 · 2008 · 2009 · 2010 · 2011 · 2012 · 2013 · 2014 · 2015 · 2016 · 2017 · 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024